A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Boston Scientific Corporation; Teleflex; Getz Healthcare; Bio-Excel</li><li>Grant Support/Research Contract - Asahi; Reflow Medical</li><li>Equity/Stock(s)/Options - Seiglar Medical</li></ul>